Multiple Sclerosis
Conference Coverage
Natalizumab switch to moderate-efficacy DMT increases disability risk
“Patients transitioning from natalizumab to another high-efficacy therapy have better inflammatory and disability outcomes, compared with those...
Conference Coverage
High levels of air pollution linked to increased MS risk
“Countermeasures that cut air pollution can be important for public health, not only to reduce deaths related to cardiac and pulmonary diseases...
MS Briefs
Progressive multiple sclerosis linked to faster retinal layer thinning
MS Briefs
Newly diagnosed MS patients more likely to have impaired cognitive function
MS Briefs
T1-hypointense count corrected by T2/FLAIR lesion volume indicates clinical severity in MS
MS Briefs
Exclusive breastfeeding lowers the risk of postpartum MS relapse
News
Neurologists’ pay gets a boost, most happy with career choice
Neurologists’ average annual income this year rose to $280,000, up from $267,000 last year.
Conference Coverage
Natalizumab bests fingolimod for relapsing-remitting MS
More patients taking natalizumab versus fingolimod reached NEDA at one year.
Conference Coverage
Serum NfL in early MS can help predict clinical course
Higher serum NfL within 5 years of MS diagnosis carries a higher risk of long term-clinical disability and higher risk of developing progressive...
Conference Coverage
Initial high-efficacy MS therapy tied to less disability later